NDC 72572-098-01 - Methylprednisolone Sodium Succinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72572-098
- Requested NDC
- 72572-098-01
- Package NDCs from labels
- 72572-098-01, 72572-098-25
- Manufacturer
- Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A.
- Effective date
- 2026-02-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| METHYLPREDNISOLONE - Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | 2026-02-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72572-098-01 | Methylprednisolone Sodium Succinate | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 1 | 2 | |
| 72572-098-25 | Methylprednisolone Sodium Succinate | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72572-098-01 | EA - Each | 72572-098 | 2601f4de-34b4-4e08-968e-20411b80d0a4 | 1 | 2026-03-17 |
| 72572-098-25 | EA - Each | 72572-098 | 6bdfbdb4-a2c2-4e2b-bbcf-409e6781830b | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | ae524bdb-9fd0-49f9-802d-465a374c175b | 2026-09-08 | Warnings, Adverse reactions | ANDA203125 1743704 LEC9GKY20K |
| Para-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 9f8f646e-634a-47ff-b208-b2249d685e55 | 2026-08-11 | Warnings | GR686LBA74 |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | HF Acquisition Co LLC, DBA HealthFirst | 559427ac-9fc6-96f5-e063-6294a90a0b30 | 2026-07-24 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Sportpharm LLC | 0cb0ba76-067f-46c4-a5d8-b585d5ecafe3 | 2026-07-23 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 68ef8ec4-16de-4a8c-8696-b09359660380 | 2026-07-17 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 7271310c-7764-4812-aa30-a5e90987c7a9 | 2026-06-25 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Eugia US LLC | 2035f00e-2299-473a-b004-cb93f541cfa9 | 2026-06-12 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | ea2f9b6f-2375-40a6-8b97-b607b9f3ac63 | 2026-06-04 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | A-S Medication Solutions | 8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9 | 2026-05-29 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 2af28649-2553-4bcc-9cb1-c73f7cec76d5 | 2026-05-20 | Warnings, Adverse reactions | 1743704 311659 LEC9GKY20K |
| Methylprednisolone sodium succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | f339882f-c380-4022-bdcd-94556a7926aa | 2026-04-15 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | decceb81-e922-4b72-a278-3ed80f4adb04 | 2026-03-18 | Warnings, Adverse reactions | 311659 LEC9GKY20K |
| CVS Pharmacy | SALINE LAXATIVE | CVS Pharmacy | edd58c52-18de-4ec4-aec3-44f3e17607a7 | 2026-02-17 | Warnings | GR686LBA74 |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 060bcf13-ce9e-488c-ad43-9d66abb23b18 | 2026-02-17 | Warnings, Adverse reactions | LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Civica, Inc. | 2e6020f5-a486-41cc-8956-58b5f6751aa2 | 2026-02-17 | Warnings, Adverse reactions | ANDA203125 72572-098-25 72572-097-25 72572-098-01 72572-097-01 72572-098 72572-097 72572009801 1743704 311659 d23fe534-8717-46d3-b2f6-f89f57b30426 2e6020f5-a486-41cc-8956-58b5f6751aa2 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 05d95a56-b03a-4d5b-9877-2853ac470fa1 | 2026-02-13 | Warnings, Adverse reactions | ANDA203125 1743704 311659 LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Hikma Pharmaceuticals USA Inc. | 2e540674-0915-4498-8e2b-751c7e97532a | 2026-02-13 | Warnings, Adverse reactions | LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 2026-01-30 | Warnings, Adverse reactions | 1743704 LEC9GKY20K |
| Equate Ready-to-Use Enema Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | WalMart | 04c7440e-5b25-4b63-9604-321298d51021 | 2026-01-29 | Warnings | GR686LBA74 |
| Quality Choice Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Chain Drug Marketing Association | 1cac3b6b-155b-47bb-bb79-17c55d345736 | 2026-01-28 | Warnings | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.